Millennium Management’s Ventyx Biosciences VTYX Stock Holding History

Millennium Management’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-50,000	Closed	-$1.74M	–	6599
2023 Q3	$1.74M	Sell	50,000 -20,000	-29%	-$691K	﹤0.01%	3693
2023 Q2	$2.3M	Buy	70,000 +35,000	+100%	+$1.21M	﹤0.01%	3355
2023 Q1	$1.17M	Buy	+35,000	New	+$1.36M	﹤0.01%	3943

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Millennium Management's VTYX Position: Q1 2026 in Review

Millennium Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 989,917 shares — an estimated $8.94M sold.

Millennium Management first reported a position in VTYX in Q4 2021 and held it in 15 quarters. The position peaked at $8.94M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Millennium Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Millennium Management sold 989,917 Ventyx Biosciences shares in Q1 2026, an estimated $8.94M.
Millennium Management first reported a position in Ventyx Biosciences in Q4 2021 and held it in 15 quarters.
Millennium Management's Ventyx Biosciences position peaked at $8.94M in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.